Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 72205-031
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 72205-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Vial-label (Decitabine Vial Label)
This is a description of a medication named Decitabine. It is meant for injection, with a concentration of 50 mg per dose for intravenous infusion only. The medication is classified as a Cytotoxic Agent and is provided in a single-dose series vial. Any unused medication should be discarded. The packaging contains 50 mg of Decitabine along with other ingredients including monobasic potassium phosphate and sodium hydroxide. The packaging also includes dosage instructions and precautions. The medication should be stored at 250 Celsius and distributed by Novadoz Pharmaceuticals LLC. The details of the LOT number and expiry period are provided, and these details are printed during packaging.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.